Trial NCT01170650

View at ClinicalTrials.gov 
Org. Study IDs: 8109-002
Secondary IDs: EC-FV-06

Last trial update was posted on 2021-09-30

MeSH Interventions

Doxorubicin Liposomal doxorubicin

MeSH Conditions

Carcinoma, Ovarian Epithelial Ovarian Neoplasms

Other Conditions

Ovarian Cancer

Stopping Reasons

DSMB decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID